Shaun A. Fleming

机构：The Alfred Hospital, Alfred Health · ORCID：0000-0002-9734-5616

发表论文 130 篇 · 总被引 2770 次 · h-index 20

代表论文

• Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial (2025 · The Lancet Haematology · 被引 20)
• Neurotoxicity associated with chimeric antigen receptor T-cell therapy (2025 · Journal of Neuroimmunology · 被引 15)
• Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia (2025 · Blood Neoplasia · 被引 6)
• Results of the APG2575AU101 Study of lisaftoclax (APG-2575) combined with azacitidine (AZA) in patients with newly diagnosed (ND) or prior venetoclax–exposed myeloid malignancies (2025 · Blood · 被引 4)
• Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach (2025 · Internal Medicine Journal · 被引 3)
• Repeatable Battery for the Assessment of Neuropsychological Status: Preliminary Utility for Subacute Cognitive Monitoring after Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T-Cell Therapy (2025 · Transplantation and Cellular Therapy · 被引 2)